Luxembourg Ministry of Health eHealth Service Platform Study

Luxembourg Ministry of Health eHealth Service Platform Study
This report analyses the opportunities for Luxembourg to implement an interoperability platform for electronic health services and provides recommendations for this platform as well as for related preliminary decisions to be taken. In 2006, the Government Council of Luxembourg approved a national eHealth plan which was developed by a working group of stakeholders in the healthcare sector in Luxembourg. This national eHealth plan recommended a number of measures with regard to interoperability such as the implementation of a common telematic platform to support sharing and exchange of medical information but also a number of healthcare specific applications.

The national eHealth plan already pointed out that interoperability is a major challenge, as well as organisational challenges. However, the national eHealth plan was still too high-level, without a clearly defined and realistic implementation scenario. In particular, a specific interoperability roadmap was missing. Hence, this roadmap and the related interoperability platform have become a priority.

As the Ministry of Health of Luxembourg wishes to define the optimal way to move forward in the national eHealth programme, PwC has been requested to conduct a study on the costs and benefits of an interoperability platform for Luxembourg. This study comprises a comparative analysis of eHealth services in other countries and transposes the results - where applicable - to the Luxembourg healthcare context.

Download: Luxembourg Ministry of Health eHealth Service Platform Study (.pdf, 4.810 KB).

Download from eHealthNews.eu Portal's mirror: Luxembourg Ministry of Health eHealth Service Platform Study (.pdf, 4.810 KB).

Most Popular Now

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...